These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 25724413

  • 1. Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.
    Liu WH, Ren LN, Wang X, Wang T, Zhang N, Gao Y, Luo H, Navarro-Alvarez N, Tang LJ.
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1767-78. PubMed ID: 25724413
    [Abstract] [Full Text] [Related]

  • 2. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
    Caviglia GP, Abate ML, Gaia S, Petrini E, Bosco C, Olivero A, Rosso C, Ciancio A, Pellicano R, Saracco GM, Rizzetto M, Smedile A.
    Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
    [Abstract] [Full Text] [Related]

  • 3. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A, Ghosh A, Datta S, Dasgupta D, Das S, Ray S, Gupta S, Datta S, Chowdhury A, Chatterjee R, Mohapatra SK, Banerjee S.
    Int J Cancer; 2016 Jun 01; 138(11):2732-44. PubMed ID: 26756996
    [Abstract] [Full Text] [Related]

  • 4. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE, Fawzy NA, El-Sheikh SM, Soliman ME.
    Mol Diagn Ther; 2015 Aug 01; 19(4):213-20. PubMed ID: 26133725
    [Abstract] [Full Text] [Related]

  • 5. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
    Wang Y, Zhang C, Zhang P, Guo G, Jiang T, Zhao X, Jiang J, Huang X, Tong H, Tian Y.
    Cancer Med; 2018 May 01; 7(5):1670-1679. PubMed ID: 29573235
    [Abstract] [Full Text] [Related]

  • 6. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S, Bhowmik S, Majumdar S, Goswami A, Chakraborty J, Gupta S, Aggarwal S, Ray S, Chatterjee R, Bhattacharyya S, Dutta M, Datta S, Chowdhury A, Dhali GK, Banerjee S.
    Int J Cancer; 2020 Nov 15; 147(10):2934-2947. PubMed ID: 32441313
    [Abstract] [Full Text] [Related]

  • 7. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 15; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 8. The Expressions of CD44, CD90 and Alpha Fetoprotein Biomarkers in Indonesian Patients with Advanced Liver Disease: an Observational Study.
    Mustika S, Wijaya H, Pratomo B.
    Acta Med Indones; 2019 Apr 15; 51(2):137-144. PubMed ID: 31383828
    [Abstract] [Full Text] [Related]

  • 9. Performance of Alpha Fetoprotein in Combination with Alpha-1-acid Glycoprotein for Diagnosis of Hepatocellular Carcinoma Among Liver Cirrhosis Patients.
    Gani RA, Suryamin M, Hasan I, Lesmana CR, Sanityoso A.
    Acta Med Indones; 2015 Jul 15; 47(3):216-22. PubMed ID: 26586387
    [Abstract] [Full Text] [Related]

  • 10. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F, Ying H, He B, Pan Y, Sun H, Wang S.
    Tumour Biol; 2016 Apr 15; 37(4):4945-53. PubMed ID: 26531720
    [Abstract] [Full Text] [Related]

  • 11. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D, Chen L, Liu X, Wang X, Xi Q, Luo Y, Zhang N, Guo H.
    Tumour Biol; 2016 May 15; 37(5):6539-49. PubMed ID: 26637228
    [Abstract] [Full Text] [Related]

  • 12. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH, Zayed N, Riad NM, Tamim HH, Shahin RMH, Labib DA, ELsheikh SM, Moneim RA, Yosry A, Khalifa RH.
    Virus Res; 2018 Aug 15; 255():77-84. PubMed ID: 30003924
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
    Seo SI, Kim HS, Kim WJ, Shin WG, Kim DJ, Kim KH, Jang MK, Lee JH, Kim JS, Kim HY, Kim DJ, Lee MS, Park CK.
    World J Gastroenterol; 2015 Apr 07; 21(13):3928-35. PubMed ID: 25852278
    [Abstract] [Full Text] [Related]

  • 14. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X, Chi X, Gong Q, Gao L, Niu Y, Chi X, Cheng M, Si Y, Wang M, Zhong J, Niu J, Yang W.
    PLoS One; 2015 Apr 07; 10(5):e0127518. PubMed ID: 25996938
    [Abstract] [Full Text] [Related]

  • 15. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Chang TS, Wu YC, Tung SY, Wei KL, Hsieh YY, Huang HC, Chen WM, Shen CH, Lu CH, Wu CS, Tsai YH, Huang YH.
    Am J Gastroenterol; 2015 Jun 07; 110(6):836-44; quiz 845. PubMed ID: 25869392
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    Ji J, Wang H, Li Y, Zheng L, Yin Y, Zou Z, Zhou F, Zhou W, Shen F, Gao C.
    PLoS One; 2016 Jun 07; 11(4):e0153227. PubMed ID: 27070780
    [Abstract] [Full Text] [Related]

  • 17. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
    Cao B, Yang L, Rong W, Feng L, Han N, Zhang K, Cheng S, Wu J, Xiao T, Gao Y.
    Int J Clin Exp Pathol; 2015 Jun 07; 8(12):16046-54. PubMed ID: 26884881
    [Abstract] [Full Text] [Related]

  • 18. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT, Liu RB, Liang YY, Hasan AME, Wang HY, Shao Q, Zhang ZC, Wang J, He CY, Wang F, Shao JY.
    Liver Int; 2017 Jun 07; 37(6):888-896. PubMed ID: 28061012
    [Abstract] [Full Text] [Related]

  • 19. Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma.
    Zhang Y, Li T, Qiu Y, Zhang T, Guo P, Ma X, Wei Q, Han L.
    Medicine (Baltimore); 2017 Jan 07; 96(2):e5642. PubMed ID: 28079796
    [Abstract] [Full Text] [Related]

  • 20. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
    Giannini EG, Marenco S, Borgonovo G, Savarino V, Farinati F, Del Poggio P, Rapaccini GL, Anna Di Nolfo M, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F, Italian Liver Cancer (ITA.LI.CA) group.
    Hepatology; 2012 Oct 07; 56(4):1371-9. PubMed ID: 22535689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.